These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12706076)

  • 21. Binding of hepatitis C virus to CD81.
    Pileri P; Uematsu Y; Campagnoli S; Galli G; Falugi F; Petracca R; Weiner AJ; Houghton M; Rosa D; Grandi G; Abrignani S
    Science; 1998 Oct; 282(5390):938-41. PubMed ID: 9794763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.
    Tseng CT; Klimpel GR
    J Exp Med; 2002 Jan; 195(1):43-9. PubMed ID: 11781364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.
    Hadlock KG; Lanford RE; Perkins S; Rowe J; Yang Q; Levy S; Pileri P; Abrignani S; Foung SK
    J Virol; 2000 Nov; 74(22):10407-16. PubMed ID: 11044085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus entry and the tetraspanin CD81.
    Farquhar MJ; Harris HJ; McKeating JA
    Biochem Soc Trans; 2011 Apr; 39(2):532-6. PubMed ID: 21428934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small molecule inhibition of hepatitis C virus E2 binding to CD81.
    VanCompernolle SE; Wiznycia AV; Rush JR; Dhanasekaran M; Baures PW; Todd SC
    Virology; 2003 Sep; 314(1):371-80. PubMed ID: 14517089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry.
    Bertaux C; Dragic T
    J Virol; 2006 May; 80(10):4940-8. PubMed ID: 16641285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD81 is an entry coreceptor for hepatitis C virus.
    Cormier EG; Tsamis F; Kajumo F; Durso RJ; Gardner JP; Dragic T
    Proc Natl Acad Sci U S A; 2004 May; 101(19):7270-4. PubMed ID: 15123813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
    Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP
    World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
    Morikawa K; Zhao Z; Date T; Miyamoto M; Murayama A; Akazawa D; Tanabe J; Sone S; Wakita T
    J Med Virol; 2007 Jun; 79(6):714-23. PubMed ID: 17457918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.
    Wellnitz S; Klumpp B; Barth H; Ito S; Depla E; Dubuisson J; Blum HE; Baumert TF
    J Virol; 2002 Feb; 76(3):1181-93. PubMed ID: 11773394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.
    Roccasecca R; Ansuini H; Vitelli A; Meola A; Scarselli E; Acali S; Pezzanera M; Ercole BB; McKeating J; Yagnik A; Lahm A; Tramontano A; Cortese R; Nicosia A
    J Virol; 2003 Feb; 77(3):1856-67. PubMed ID: 12525620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of transferrin receptor 1 as a hepatitis C virus entry factor.
    Martin DN; Uprichard SL
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10777-82. PubMed ID: 23754414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
    Drummer HE; Boo I; Maerz AL; Poumbourios P
    J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell fusion activity of hepatitis C virus envelope proteins.
    Takikawa S; Ishii K; Aizaki H; Suzuki T; Asakura H; Matsuura Y; Miyamura T
    J Virol; 2000 Jun; 74(11):5066-74. PubMed ID: 10799580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
    Triyatni M; Vergalla J; Davis AR; Hadlock KG; Foung SK; Liang TJ
    Virology; 2002 Jun; 298(1):124-32. PubMed ID: 12093180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro binding of hepatitis C virus to CD81-positive and -negative human cell lines.
    Sasaki M; Yamauchi K; Nakanishi T; Kamogawa Y; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):74-9. PubMed ID: 12519228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.
    Higginbottom A; Quinn ER; Kuo CC; Flint M; Wilson LH; Bianchi E; Nicosia A; Monk PN; McKeating JA; Levy S
    J Virol; 2000 Apr; 74(8):3642-9. PubMed ID: 10729140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
    Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
    Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.
    Qin ZL; Ju HP; Gao TT; Wang WB; Ren H; Zhao P; Qi ZT
    J Gen Virol; 2015 Jun; 96(Pt 6):1389-1399. PubMed ID: 25701820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.